1. Home
  2. TILE vs WVE Comparison

TILE vs WVE Comparison

Compare TILE & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TILE
  • WVE
  • Stock Information
  • Founded
  • TILE 1973
  • WVE 2012
  • Country
  • TILE United States
  • WVE Singapore
  • Employees
  • TILE N/A
  • WVE N/A
  • Industry
  • TILE Home Furnishings
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TILE Consumer Discretionary
  • WVE Health Care
  • Exchange
  • TILE Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TILE 1.1B
  • WVE 984.9M
  • IPO Year
  • TILE N/A
  • WVE 2015
  • Fundamental
  • Price
  • TILE $19.83
  • WVE $6.25
  • Analyst Decision
  • TILE Buy
  • WVE Strong Buy
  • Analyst Count
  • TILE 1
  • WVE 11
  • Target Price
  • TILE $30.00
  • WVE $20.91
  • AVG Volume (30 Days)
  • TILE 345.2K
  • WVE 1.3M
  • Earning Date
  • TILE 05-02-2025
  • WVE 05-08-2025
  • Dividend Yield
  • TILE 0.20%
  • WVE N/A
  • EPS Growth
  • TILE 44.62
  • WVE N/A
  • EPS
  • TILE 1.46
  • WVE N/A
  • Revenue
  • TILE $1,323,328,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • TILE $5.19
  • WVE N/A
  • Revenue Next Year
  • TILE $4.91
  • WVE N/A
  • P/E Ratio
  • TILE $13.62
  • WVE N/A
  • Revenue Growth
  • TILE 5.41
  • WVE N/A
  • 52 Week Low
  • TILE $14.13
  • WVE $4.25
  • 52 Week High
  • TILE $27.34
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TILE 48.13
  • WVE 44.91
  • Support Level
  • TILE $18.74
  • WVE $5.98
  • Resistance Level
  • TILE $20.54
  • WVE $6.30
  • Average True Range (ATR)
  • TILE 0.54
  • WVE 0.31
  • MACD
  • TILE -0.10
  • WVE 0.03
  • Stochastic Oscillator
  • TILE 36.70
  • WVE 47.37

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: